It can mask residual vascularity on CT imaging and its use is not recommended ... Medline using the following key words: 'hepatocellular carcinoma' or 'HCC' or 'hepatic tumor' or 'liver tumor ...

Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.

Hepatocellular carcinoma starts in the primary type of liver ... A liver cancer diagnosis can be made using ultrasound, MRIs, ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Hepatocellular carcinoma is the most common form of primary ... typically involves imaging tests—such as ultrasound, CT scans and MRIs—alongside blood tests that measure liver function and ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds momentum with both Fast Track and Orphan Drug Designations.